| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/25/2002 | CN1370554A Kidney-benefiting and tranquilizing medicine and its prepn |
| 09/25/2002 | CN1370553A Brain-invigorating tic-stopping medicine and its prepn |
| 09/25/2002 | CN1370552A Fatty acid synthetase inhibitor and its prepn and application |
| 09/25/2002 | CN1370551A Fatty acid synthetase inhibitor and its prepn and application |
| 09/25/2002 | CN1370550A Fatty acid synthetase inhibitor and its prepn and application |
| 09/25/2002 | CN1370544A Nutritious health care woodfrog egg oil caspule with blood lipoid reducing function and its prepn |
| 09/25/2002 | CN1370543A Antilipemic nutritious health care soft capsule and its prepn |
| 09/25/2002 | CN1370536A Exogenous medicinal animal active gene liquid and its extraction method and application |
| 09/25/2002 | CN1370531A Combined therapy |
| 09/25/2002 | CN1370529A Medicine for treating spinal cord lesion |
| 09/25/2002 | CN1370526A Treating method of nuclear factor-KB mediated diseases and dysfuction |
| 09/25/2002 | CN1370525A Application of glycine in preparing medicine |
| 09/25/2002 | CN1370467A Vital energy regualting and blood circulation-promoting health beverage |
| 09/25/2002 | CN1370465A Vigor-giving health beverage |
| 09/25/2002 | CN1370443A Composition of ganglioside and bean food and its application |
| 09/25/2002 | CN1370429A Health food |
| 09/25/2002 | CN1091443C New imidazoline compounds, process for preparing them and pharmaceutical composition containing them |
| 09/25/2002 | CN1091368C Pharmaceutical composition comprising coenzyme Q10 |
| 09/24/2002 | WO2001072289A2 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 09/24/2002 | US6455709 Such as 1,3-dimethyl-fulleropyrrolidine-1,3-dicarboxylic n-amide oligomer |
| 09/24/2002 | US6455700 Process for preparing guanidine and amidine derivatives |
| 09/24/2002 | US6455574 Administering a combinations of amlodipine or a pharmaceutically acceptable acid addition salt thereof and atorvastatin or a pharmaceutically acceptable salt thereof for treatment of combined hypertension and hyperlipidemia |
| 09/24/2002 | US6455573 Synthesizing salacinol, its stereoisomers, and non-naturally occurring selenium and nitrogen analogues thereof |
| 09/24/2002 | US6455572 Estrogen agonist/antagonist metabolites |
| 09/24/2002 | US6455571 Inhibitors of neuraminidases |
| 09/24/2002 | US6455569 Connective tissue softening |
| 09/24/2002 | US6455567 Treating dermatological disorders by administering a 3-(pyrrolidin-2-ylmethyl)-5-(aminosulfonylmethyl)indole |
| 09/24/2002 | US6455562 Cyclic AMP-specific phosphodiesterase inhibitors |
| 09/24/2002 | US6455561 Administering benzofuran derivative for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase iv or tumour necrosis factor |
| 09/24/2002 | US6455542 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 09/24/2002 | US6455534 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 09/24/2002 | US6455533 Substituted benzhydrylpiperazines such as cetirizine, hydroxyzine, efletirizine, meclizine and buclizine, the optically active isomers thereof and the pharmaceutically acceptable salts thereof. |
| 09/24/2002 | US6455532 Pyrazinone thrombin inhibitors |
| 09/24/2002 | US6455529 Adhesion receptor antagonists |
| 09/24/2002 | US6455527 High affinity ligands for nociceptin receptor ORL-1 |
| 09/24/2002 | US6455525 Heterocyclic substituted pyrazolones |
| 09/24/2002 | US6455524 Medicament compositions based on anticholinergically-effective compounds and beta-mimetics |
| 09/24/2002 | US6455523 Inhibitors of farnesyl protein transferase |
| 09/24/2002 | US6455522 Cyclic sulfonamide derivatives as metalloproteinase inhibitors |
| 09/24/2002 | US6455518 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-O-(2-hydroxyethyl)-rapamycin |
| 09/24/2002 | US6455517 For therapy of conditions or diseases that are estrogen-dependent, i.e., are estrogen-induced or estrogen-stimulated |
| 09/24/2002 | US6455516 Administering epiallopregnanolone as antidepressant, cognition activator, or antiepileptic agent; treatment of premenstrual syndrome |
| 09/24/2002 | US6455513 Chemical compounds |
| 09/24/2002 | US6455510 Chemical Compounds |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/24/2002 | US6455291 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/24/2002 | US6455286 Psoralens for pathogen inactivation |
| 09/24/2002 | US6455078 Grinding and mixing the plant of diffuse hedyotis, dried rhizome of bistort rhizome, giant knotweed rhizome, dried ripe fruit of chinese magnoliviavine fruit to form mixture, boiling in water, filtering and concentrating the extract |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | CA2404322A1 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 09/24/2002 | CA2261426C Benzimidazole cyclooxygenase-2-inhibitors |
| 09/24/2002 | CA2257807C Improved methods for the synthesis of chemical compounds having pde-iv inhibitory activity |
| 09/24/2002 | CA2220458C Form iii crystalline (r-(r*,r*)-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-((phenylamino)carbonyl)-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 09/24/2002 | CA2105487C Antiviral nucleoside combination |
| 09/24/2002 | CA2096223C Treatment for tissue ulceration |
| 09/23/2002 | WO2001070689A1 DIPHENYLALKYLAMINE DERIVATIVES USEFUL AS OPIOID δ RECEPTOR AGONISTS |
| 09/23/2002 | CA2404280A1 Diphenylalkylamine derivatives useful as opioid .delta. receptor agonists |
| 09/23/2002 | CA2341952A1 Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases |
| 09/20/2002 | WO2001070704A1 Novel imidazole derivatives with anti-inflammatory activity |
| 09/20/2002 | CA2403732A1 Novel imidazole derivatives with anti-inflammatory activity |
| 09/19/2002 | WO2002073235A2 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 09/19/2002 | WO2002073208A2 Anti-epileptogenic agents |
| 09/19/2002 | WO2002072888A2 Polymorphisms in the human cmoat gene and uses thereof |
| 09/19/2002 | WO2002072830A2 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | WO2002072794A2 Immunoglobulin superfamily proteins |
| 09/19/2002 | WO2002072780A2 Igf antagonist peptides |
| 09/19/2002 | WO2002072778A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | WO2002072769A2 Human serpin polypeptides |
| 09/19/2002 | WO2002072636A2 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/19/2002 | WO2002072620A1 Tumour targeting prodrugs activated by metallo matrixproteinases |
| 09/19/2002 | WO2002072608A2 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS |
| 09/19/2002 | WO2002072599A1 Anti-apoptosis agents or regeneration promoters comprising ginsenosides |
| 09/19/2002 | WO2002072584A2 Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 09/19/2002 | WO2002072579A1 Triazolopyridines as anti-inflammatory agents |
| 09/19/2002 | WO2002072577A2 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| 09/19/2002 | WO2002072576A1 Benzimidazole anti-inflammatory compounds |
| 09/19/2002 | WO2002072573A1 Imidazolidine derivatives, their preparation, and their use as antinflamatory agent. |
| 09/19/2002 | WO2002072570A2 Non-imidazole compounds as histamine h3 antagonists |
| 09/19/2002 | WO2002072569A1 P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same |
| 09/19/2002 | WO2002072564A1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 09/19/2002 | WO2002072562A1 Medicinal composition containing 1,3-thiazine derivative |
| 09/19/2002 | WO2002072548A2 Heterocyclic compounds and their use as histamine h4 ligands. |
| 09/19/2002 | WO2002072544A2 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/19/2002 | WO2002072542A2 Ph-dependent nmda receptor antagonists |
| 09/19/2002 | WO2002072528A1 Fluorinated trienes and their use as rxr modulators |
| 09/19/2002 | WO2002072527A2 1-butyric acid derivatives such as carbomethoxypropionyl cyanide or leflunomide derivatives, and the therapeutic use thereof |
| 09/19/2002 | WO2002072202A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 09/19/2002 | WO2002072151A1 Enzyme-activated cytostatic conjugates with integrin ligands |
| 09/19/2002 | WO2002072149A1 Methods for reducing fat by administration of adiponectin |
| 09/19/2002 | WO2002072147A1 Medicinal compositions containing bile acid transporter inhibitor |
| 09/19/2002 | WO2002072145A1 Remedies for depression containing ep1 antagonist as the active ingredient |
| 09/19/2002 | WO2002072134A1 Remedies for arthritis deformans and remedies for rheumatoid arthritis |
| 09/19/2002 | WO2002072127A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 09/19/2002 | WO2002072112A1 Use of selenite or preparations containing selenite for treating wounds |
| 09/19/2002 | WO2002072104A2 Antihypertensive agent and cholesterol absorption inhibitor combination therapy |
| 09/19/2002 | WO2002072094A2 Use of neuroactive substances and combinations thereof for the treatment of parkinsons disease |
| 09/19/2002 | WO2002072093A2 Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
| 09/19/2002 | WO2002072092A1 Method for increasing leptin levels using nicotinic acid compounds |
| 09/19/2002 | WO2002072091A1 Anticancer drug-tolerance inhibitors |
| 09/19/2002 | WO2002072090A1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |